Occurrence of canine and human leishmaniosis between 2020 and 2022 in the Alto Tâmega region (Portugal): a descriptive study of seropositivity in clinically suspected dogs, a status report on the occurrence of cases in humans and perception of the disease by pet tutors


M Rodrigues
L Cardoso
https://orcid.org/0000-0002-6145-7560
JÁ Costa
https://orcid.org/0000-0003-1745-1193
Abstract

Zoonotic visceral leishmaniosis is a severe neglected zoonotic parasitic disease caused by Leishmania infantum with dogs as the major reservoir hosts. Although the European Centre for Disease Prevention and Control (ECDC) reported, in 2022, no human or animal cases in the Alto Tâmega region between 2009-2020, the truth is that there were notified cases. The present study main objective was to determine the occurrence of infection and disease among 217 clinically suspected dogs subjected to serological tests in a Reference Veterinary Clinic in the Alto Tâmega region and among human patients of the Public Health Unit of Alto Tâmega e Barroso actuation area, in northern Portugal. In addition, a questionnaire was presented to 100 of the clinic's clients during the last fortnight of October 2022. The majority of sampled dogs had no defined breed (43.7%), they were mainly males (56.7%) and under 10 years of age (29.5%). Between January 2020 and September 2022, there were 64 seropositive dogs among those subjected to anti-Leishmania antibody detection, indicating that canine leishmaniosis (CanL) had 29.5% of occurrence within the sample of the population studied. Among the seropositive dogs, 44.4% were mongrel dogs and 56.52% were males. There were no reported human cases between 2020 and 2022. The majority of the questionnaire respondents believed that leishmaniosis does not affect humans (39.0%) and that is not a public health issue (33.0%) and a
considerable part of the sample does not have a position about those questions (33.0% and 42.0%, respectively). Based on the survey sample collected, most people may not associate the disease with a zoonosis and, therefore, there may be a risk of underdiagnosis and underreport, as there is no demand for treatment and medical diagnosis directed towards some suspected cases or because human cutaneous leishmaniosis is not a notifiable disease. An improvement in education of the population in areas of endemicity is needed to reach the objective of minimizing the impact of leishmaniosis, perform a proper diagnosis and treatment, and ensure a safer bond between animals and humans.

Article Details
  • Rubrik
  • Research Articles
Downloads
Keine Nutzungsdaten vorhanden.
Autor/innen-Biografien
L Cardoso, Universidade de Trás-os-Montes e Alto Douro

Department of Veterinary Sciences, and Animal and Veterinary Research Centre (CECAV), University of
Trás-os-Montes e Alto Douro (UTAD), Vila Real, Portugal; and Associate Laboratory for Animal and
Veterinary Sciences (AL4AnimalS), Portugal.

 

JÁ Costa, Os Bichos - Clínica Veterinária

“Os Bichos” Veterinary Clinic, Chaves, Portugal.

Literaturhinweise
Azami-Conesa I, Martínez-Díaz RA, González F, Gómez-Muñoz MT
(2020) First detection of Leishmania infantum in common urban bats
Pipistrellus pipistrellus in Europe. Res Vet Sci 132:172-176.
Campino, LM (2002). Canine reservoirs and leishmaniasis: epidemiology
and disease. In Leishmania (pp. 45-57). Springer, Boston, MA.
Campino L, Maia C (2018) The role of reservoirs: canine leishmaniasis.
In: Drug Resistance in Leishmania Parasites - Consequences, Molecular Mechanism and Possible Treatments. 2nd ed, Springer Verlag,
Vienna: pp 45-64.
Cardoso L, Schallig H, Persichetti MF, Pennisi M G (2021) New epidemiological aspects of animal leishmaniosis in Europe: the role of vertebrate hosts other than dogs. Pathogens 10:307.
DGS (2017) Doenças de declaração obrigatória 2013-2016. Volume II -
Regiões. Direção-Geral da Saúde. Directorate-General for Health,
Lisbon.
ECDC (2022) Surveillance, prevention and control of leishmaniases in the
European Union and its neighbouring countries. European Centre for
Disease Prevention and Control, Stockholm.
Gálvez, R., Miró, G., Descalzo, M. A., Nieto, J., Dado, D., Martín, O., ...
& Molina, R. (2010). Emerging trends in the seroprevalence of canine
leishmaniosis in the Madrid region (central Spain). Vet. Parasitol.,
(3-4), 327-334.
Gonzalez-Lombana C, Gimblet C, Bacellar O, Oliveira WW, Passos S,
Carvalho LP, Goldschmidt M, Carvalho EM, Scott P (2013) IL-17
mediates immunopathology in the absence of IL-10 following Leishmania major infection. PLOS Pathog 9:e1003243.
INE (2020) Estatísticas da Saúde - 2018. Instituto Nacional de Estatística.
Statistics Portugal, Lisbon.
Maia C, Fraga DBM, Cristóvão J, Borja LS, da Silva Solcà M, Campino
L, Veras PST, Gonçalves L (2022) Leishmania exposure in dogs from
two endemic countries from New and Old Worlds (Brazil and Portugal): evaluation of three serological tests using Bayesian Latent Class
Models. Parasit. vectors 15:202.
Miranda, S., Roura, X., Picado, A., Ferrer, L., & Ramis, A. (2008). Characterization of sex, age, and breed for a population of canine leishmaniosis diseased dogs. Res. J. Vet. Sci., 85(1), 35-38.
Miró, G, Montoya, A, Mateo, M, Alonso, A, García, S, García, A, ... &
Molina, R (2007). A leishmaniosis surveillance system among stray
dogs in the region of Madrid: ten years of serodiagnosis (1996-
. Parasitol. Res., 101(2), 253-257.
Miró, G., & López-Vélez, R. (2018). Clinical management of canine
leishmaniosis versus human leishmaniasis due to Leishmania infantum: Putting “One Health” principles into practice. Vet. Parasitol.,
, 151-159.
Morales-Yuste M, Martín-Sánchez J, Corpas-Lopez V (2022) Canine
leishmaniasis: Update on epidemiology, diagnosis, treatment, and
prevention.Vet Sci9:387.
Mihalca AD, Cazan CD, Sulesco T, Dumitrache MO (2019) A historical
review on vector distribution and epidemiology of human and animal
leishmanioses in Eastern Europe.Res Vet Sci123:185-191.
Rombolà, P., Barlozzari, G., Carvelli, A., Scarpulla, M., Iacoponi, F., &
Macri, G. (2021). Seroprevalence and risk factors associated with exposure to Leishmania infantum in dogs, in an endemic Mediterranean
region. PLoS One, 16(1), e0244923.
SNS (2018). Doenças de declaração obrigatória. Serviço Nacional
Solano-Gallego L, Morell P, Arboix M, Alberola J, Ferrer L (2001) Prevalence of Leishmania infantum infection in dogs living in an area of
canine leishmaniasis endemicity using PCR on several tissues and
serology. J Clin Microbiol 39:560-563.
Solano-Gallego, L., Miró, G., Koutinas, A., Cardoso, L., Pennisi, M. G.,
Ferrer, L., ... &Baneth, G. (2011). LeishVet guidelines for the practical management of canine leishmaniosis. Parasit. vectors, 4, 1-16.
Velez R, Gállego M (2020) Commercially approved vaccines for canine
leishmaniosis: a review of available data on their safety and efficacy.
Trop MedInt Health25:540-557.
WHO (2022) Leishmaniasis. World Health Organization.https://www.
who.int/news-room/fact-sheets/detail/leishmaniasis[accessed01 November 2022]
Am häufigsten gelesenen Artikel dieser/dieses Autor/in